BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tomaiuolo R, Degiorgio D, Coviello D, Baccarelli A, Elce A, Raia V, Motta V, Seia M, Castaldo G, Colombo C. An MBL2 haplotype and ABCB4 variants modulate the risk of liver disease in cystic fibrosis patients: A multicentre study. Digestive and Liver Disease 2009;41:817-22. [DOI: 10.1016/j.dld.2009.03.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Prentice B, Mckay K, Selvadurai H, Robinson PD, Abel F, Fitzgerald DA. Question 6: Is there a role for Mannose-Binding Lectin measurement in Cystic Fibrosis management? Paediatric Respiratory Reviews 2016;19:46-8. [DOI: 10.1016/j.prrv.2015.09.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Maruotti GM, Frisso G, Calcagno G, Fortunato G, Castaldo G, Martinelli P, Sacchetti L, Salvatore F. Prenatal diagnosis of inherited diseases: 20 years’ experience of an Italian Regional Reference Centre. Clinical Chemistry and Laboratory Medicine 2013;51. [DOI: 10.1515/cclm-2013-0194] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
3 Scorza M, Elce A, Zarrilli F, Liguori R, Amato F, Castaldo G. Genetic diseases that predispose to early liver cirrhosis. Int J Hepatol 2014;2014:713754. [PMID: 25132997 DOI: 10.1155/2014/713754] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
4 Scudiero O, Monaco ML, Nigro E, Capasso M, Guida M, Sardo ADS, Prezioso D, Daniele A, Castaldo G. Mannose-binding lectin genetic analysis: possible protective role of the HYPA haplotype in the development of recurrent urinary tract infections in men. International Journal of Infectious Diseases 2014;19:100-2. [DOI: 10.1016/j.ijid.2013.10.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Tomaiuolo R, Ruocco A, Salapete C, Carru C, Baggio G, Franceschi C, Zinellu A, Vaupel J, Bellia C, Lo Sasso B, Ciaccio M, Castaldo G, Deiana L. Activity of mannose-binding lectin in centenarians. Aging Cell 2012;11:394-400. [PMID: 22239660 DOI: 10.1111/j.1474-9726.2012.00793.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
6 Chalmers JD, Fleming GB, Hill AT, Kilpatrick DC. Impact of mannose-binding lectin insufficiency on the course of cystic fibrosis: A review and meta-analysis. Glycobiology 2011;21:271-82. [PMID: 21045008 DOI: 10.1093/glycob/cwq161] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
7 Weiler CA, Drumm ML. Genetic influences on cystic fibrosis lung disease severity. Front Pharmacol. 2013;4:40. [PMID: 23630497 DOI: 10.3389/fphar.2013.00040] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
8 Giordano S, Amato F, Elce A, Monti M, Iannone C, Pucci P, Seia M, Angioni A, Zarrilli F, Castaldo G, Tomaiuolo R. Molecular and functional analysis of the large 5' promoter region of CFTR gene revealed pathogenic mutations in CF and CFTR-related disorders. J Mol Diagn 2013;15:331-40. [PMID: 23470247 DOI: 10.1016/j.jmoldx.2013.01.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
9 Scorza M, Liguori R, Elce A, Salvatore F, Castaldo G. Biological role of mannose binding lectin: From newborns to centenarians. Clinica Chimica Acta 2015;451:78-81. [DOI: 10.1016/j.cca.2015.03.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
10 Yokoyama E, Chávez-Saldaña M, Orozco L, Cuevas F, Lezana JL, Vigueras-Villaseñor RM, Rojas-Castañeda JC, Landero DA. Influence of SNPs in Genes that Modulate Lung Disease Severity in a Group of Mexican Patients with Cystic Fibrosis. Arch Med Res 2018;49:18-26. [PMID: 29703608 DOI: 10.1016/j.arcmed.2018.04.010] [Reference Citation Analysis]
11 Anzivino C, Odoardi MR, Meschiari E, Baldelli E, Facchinetti F, Neri I, Ruggiero G, Zampino R, Bertolotti M, Loria P. ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population. Dig Liver Dis. 2013;45:226-232. [PMID: 23022423 DOI: 10.1016/j.dld.2012.08.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
12 Colombo C, Vajro P, Degiorgio D, Coviello DA, Costantino L, Tornillo L, Motta V, Consonni D, Maggiore G. Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations. J Pediatr Gastroenterol Nutr. 2011;52:73-83. [PMID: 21119540 DOI: 10.1097/mpg.0b013e3181f50363] [Cited by in Crossref: 47] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
13 Sofia VM, Da Sacco L, Surace C, Tomaiuolo AC, Genovese S, Grotta S, Gnazzo M, Ciocca L, Petrocchi S, Alghisi F, Montemitro E, Martemucci L, Elce A, Lucidi V, Castaldo G, Angioni A. Extensive molecular analysis suggested the strong genetic heterogeneity of idiopathic chronic pancreatitis. Mol Med 2016;22:300-9. [PMID: 27264265 DOI: 10.2119/molmed.2016.00010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
14 Zarrilli F, Elce A, Scorza M, Giordano S, Amato F, Castaldo G. An update on laboratory diagnosis of liver inherited diseases. Biomed Res Int 2013;2013:697940. [PMID: 24222913 DOI: 10.1155/2013/697940] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
15 Dietrich CG, Geier A. Effect of drug transporter pharmacogenetics on cholestasis. Expert Opin Drug Metab Toxicol. 2014;10:1533-1551. [PMID: 25260651 DOI: 10.1517/17425255.2014.963553] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
16 Castaldo G, Tomaiuolo R. What is the role of the non-coding regions of the CFTR gene in cystic fibrosis? Expert Review of Respiratory Medicine 2014;7:327-9. [DOI: 10.1586/17476348.2013.814404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Mandal J, Malla B, Steffensen R, Costa L, Egli A, Trendelenburg M, Blasi F, Kostikas K, Welte T, Torres A, Louis R, Boersma W, Milenkovic B, Aerts J, Rohde GG, Lacoma A, Rentsch K, Roth M, Tamm M, Stolz D. Mannose-binding lectin protein and its association to clinical outcomes in COPD: a longitudinal study. Respir Res 2015;16:150. [PMID: 26684757 DOI: 10.1186/s12931-015-0306-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
18 Debray D, Corvol H, Housset C. Modifier genes in cystic fibrosis-related liver disease. Curr Opin Gastroenterol 2019;35:88-92. [PMID: 30585791 DOI: 10.1097/MOG.0000000000000508] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 8.5] [Reference Citation Analysis]
19 Paranjapye A, Ruffin M, Harris A, Corvol H. Genetic variation in CFTR and modifier loci may modulate cystic fibrosis disease severity. J Cyst Fibros 2020;19 Suppl 1:S10-4. [PMID: 31734115 DOI: 10.1016/j.jcf.2019.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
20 Amato F, Tomaiuolo R, Borbone N, Elce A, Amato J, D'errico S, De Rosa G, Mayol L, Piccialli G, Oliviero G, Castaldo G. Design, synthesis and biochemical investigation, by in vitro luciferase reporter system, of peptide nucleic acids as new inhibitors of miR-509-3p involved in the regulation of cystic fibrosis disease-gene expression. Med Chem Commun 2014;5:68-71. [DOI: 10.1039/c3md00257h] [Cited by in Crossref: 13] [Article Influence: 1.6] [Reference Citation Analysis]